Skip to main content
Fig. 5 | Respiratory Research

Fig. 5

From: New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors

Fig. 5

Factors selection and correlation analysis based on peripheral-blood immune indices of severe irAEs. a The LASSO coefficient profiles of the candidate variables; b the optimal tuning λ in the LASSO analysis selected with tenfold cross-validation via minimum criteria; c the development of severe irAEs corresponds to change-CD4+ T cells, change-CD4+/CD8+ ratio and change-CD3+CD56+CD16+NKT-like cells; d the development of severe irAEs corresponds to age and hypertension

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us